CalciMedica, TorreyPines, CBR Institute for Biomedical Research deal

CalciMedica purchased TPTX's patent application covering uses of stromal interaction molecule-1 (STIM-1) for regulating

Read the full 140 word article

User Sign In

Article Purchase

This article may not be distributed to non-subscribers

PURCHASE THIS ARTICLE FOR LIMITED ONE-TIME DISTRIBUTION AND WEBSITE POSTING $995.00 USD

PURCHASE